Carl L. Gordon

Carl L. Gordon is recorded as Board Member at Adicet Bio, Inc. (ACET) since June 1, 2023. Carl L. Gordon was last confirmed as Board Member at ArriVent BioPharma, Inc. (AVBP) in a filing dated April 28, 2025. Carl L. Gordon was last confirmed as Board Member at MBX Biosciences, Inc. (MBX) in a filing dated April 23, 2025. Carl L. Gordon was last confirmed as Board Member at Compass Therapeutics, Inc. (CMPX) in a filing dated April 29, 2025. Earlier roles on record: Board Member at Oric Pharmaceuticals, Inc. (ORIC) until November 9, 2021. Adicet Bio, Inc. reported in an 8-K filed April 17, 2025 that Carl L. Gordon resigned as Class II member of the board of directors, effective April 17, 2025. Keros Therapeutics, Inc. reported in an 8-K filed June 17, 2024 that Carl L. Gordon resigned as Chair of the Board, effective June 30, 2024. Adicet Bio, Inc. reported in an 8-K filed June 5, 2023 that Carl L. Gordon was appointed Class II director, effective June 1, 2023. Adicet Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Adicet Bio, Inc. includes Chen Schor (CEO), Nick Harvey (CFO), Stewart Abbot (COO) and 7 others.